Literature DB >> 23617231

Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review.

Josien C Regelink1, Monique C Minnema, Evangelos Terpos, Marjolein H Kamphuis, Pieter G Raijmakers, Indra C Pieters-van den Bos, Ben G F Heggelman, Rutger-Jan Nievelstein, Rene H J Otten, Danielle van Lammeren-Venema, Josee M Zijlstra, Anne I J Arens, Jacky W de Rooy, Otto S Hoekstra, Reinier Raymakers, Pieter Sonneveld, Raymond W Ostelo, Sonja Zweegman.   

Abstract

This systematic review of studies compared magnetic resonance imaging (MRI), (18) F-fluorodeoxyglucose positron emission tomography (FDG-PET), FDG-PET with computerized tomography (PET-CT) and CT with whole body X-Ray (WBXR) or (whole body) CT in order to provide evidence-based diagnostic guidelines in multiple myeloma bone disease. A comprehensive search of 3 bibliographic databases was performed; methodological quality was assessed using Quality Assessment of Diagnostic Accuracy Studies (QUADAS) criteria (score 1-14). Data from 32 directly comparative studies were extracted. The mean QUADAS score was 7·1 (3-11), with quality hampered mainly by a poor description of selection and execution criteria. All index tests had a higher detection rate when compared to WBXR, with up to 80% more lesions detected by the newer imaging techniques; MRI (1·12-1·82) CT (1·04-1·33), PET (1·00-1·58) and PET-CT (1·27-1·45). However, the modern imaging techniques detected fewer lesions in the skull and ribs. In a direct comparison CT and MRI performed equally with respect to detection rate and sensitivity. This systematic review supports the International Myeloma Working Group guidelines, which recommend that WBCT can replace WBXR. In our opinion, the equal performance of MRI also indicates that it is a valuable alternative. As lesions of the skull and ribs are underdiagnosed by modern imaging techniques we advise additional X-rays of these regions. The consequences of this approach are discussed.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23617231     DOI: 10.1111/bjh.12346

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  60 in total

Review 1.  The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma.

Authors:  Jo Caers; Nadia Withofs; Jens Hillengass; Paolo Simoni; Elena Zamagni; Roland Hustinx; Yves Beguin
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

2.  Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: Comparison with 5- and 1-mm axial images.

Authors:  Georg Homann; Katja Weisel; Deedar Farhad Mustafa; Hendrik Ditt; Konstantin Nikolaou; Marius Horger
Journal:  Skeletal Radiol       Date:  2015-04-02       Impact factor: 2.199

3.  Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states.

Authors:  F Joseph Simeone; Joel P Harvey; Andrew J Yee; Elizabeth K O'Donnell; Noopur S Raje; Martin Torriani; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2018-09-14       Impact factor: 2.199

4.  Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management

Authors: 
Journal:  Am J Hematol       Date:  2018-08-16       Impact factor: 10.047

Review 5.  International Myeloma Working Group recommendations for global myeloma care.

Authors:  H Ludwig; J S Miguel; M A Dimopoulos; A Palumbo; R Garcia Sanz; R Powles; S Lentzsch; W Ming Chen; J Hou; A Jurczyszyn; K Romeril; R Hajek; E Terpos; K Shimizu; D Joshua; V Hungria; A Rodriguez Morales; D Ben-Yehuda; P Sondergeld; E Zamagni; B Durie
Journal:  Leukemia       Date:  2013-10-09       Impact factor: 11.528

Review 6.  [Management of osseous complications in multiple myeloma].

Authors:  K Zarghooni; S Hopf; P Eysel
Journal:  Internist (Berl)       Date:  2019-01       Impact factor: 0.743

Review 7.  Minimal residual disease testing after stem cell transplantation for multiple myeloma.

Authors:  A M Sherrod; P Hari; C A Mosse; R C Walker; R F Cornell
Journal:  Bone Marrow Transplant       Date:  2015-07-20       Impact factor: 5.483

Review 8.  The Critical Role of Imaging in the Management of Multiple Myeloma.

Authors:  Shahzad Raza; Siyang Leng; Suzanne Lentzsch
Journal:  Curr Hematol Malig Rep       Date:  2017-06       Impact factor: 3.952

Review 9.  Imaging in myeloma with focus on advanced imaging techniques.

Authors:  Tara Barwick; Laure Bretsztajn; Kathryn Wallitt; Dimitri Amiras; Andrea Rockall; Christina Messiou
Journal:  Br J Radiol       Date:  2019-01-03       Impact factor: 3.039

Review 10.  Myeloma and Bone Disease.

Authors:  Cristina Panaroni; Andrew J Yee; Noopur S Raje
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.